Cortés F, Piñero J, Palitti F
Department of Cell Biology, Faculty of Biology, Seville, Spain.
Mutat Res. 1993 Aug;288(2):281-9. doi: 10.1016/0027-5107(93)90096-x.
The possible relationship between topoisomerase activities and the occurrence of SCE and chromosomal aberrations was investigated in the CHO ethyl methanesulfonate-sensitive mutant EM9 and its parental line, AA8. The Topo II inhibitor m-AMSA induced fewer SCE in EM9 than in AA8, mainly when given during the first S period. When the Topo I inhibitor camptothecin was used, it showed a higher efficiency to induce both chromosomal aberrations and SCE in EM9 than in AA8. The impact of BrdU incorporated into parental DNA on topoisomerase activity was tested using nuclear extracts from both EM9 and AA8 assayed for their ability to decatenate kinetoplast DNA by Topo II and to relax supercoiled plasmid DNA by Topo I. Taken as a whole, the results seem to indicate that there are differences between the two cell lines, consistent with the hypothesis put forward by other investigators that topoisomerases are involved in the molecular mechanism of SCE.
在CHO甲磺酸乙酯敏感突变体EM9及其亲本系AA8中,研究了拓扑异构酶活性与姐妹染色单体交换(SCE)及染色体畸变发生之间的可能关系。拓扑异构酶II抑制剂m-AMSA在EM9中诱导的SCE比在AA8中少,主要是在第一个S期给予该抑制剂时。当使用拓扑异构酶I抑制剂喜树碱时,它在EM9中诱导染色体畸变和SCE的效率比在AA8中更高。利用EM9和AA8的核提取物检测掺入亲本DNA中的溴脱氧尿苷(BrdU)对拓扑异构酶活性的影响,通过拓扑异构酶II检测其解开动质体DNA连环的能力以及通过拓扑异构酶I检测其松弛超螺旋质粒DNA的能力。总体而言,结果似乎表明这两种细胞系之间存在差异,这与其他研究者提出的拓扑异构酶参与SCE分子机制的假设一致。